Muscular Dystrophy Association Renews Partnership with ALS Therapy Development Institute to Develop New Treatments for Lou Gehrig's Disease
Thursday, January 7, 2010 - 04:42
in Health & Medicine
MDA awards $2.5 million grant to ALS TDI, of Cambridge, MA., in unique, collaborate pact to fund therpeutic treatments for deadly neurological disease. ALS TDI is on the fast track in developing treatments for ALS patients, using previous MDA funding of $18 million.